WO2004011626A3 - Assays and methods based on microcompetition with a foreign polynucleotide - Google Patents

Assays and methods based on microcompetition with a foreign polynucleotide Download PDF

Info

Publication number
WO2004011626A3
WO2004011626A3 PCT/US2003/024844 US0324844W WO2004011626A3 WO 2004011626 A3 WO2004011626 A3 WO 2004011626A3 US 0324844 W US0324844 W US 0324844W WO 2004011626 A3 WO2004011626 A3 WO 2004011626A3
Authority
WO
WIPO (PCT)
Prior art keywords
microcompetition
methods based
assays
foreign polynucleotide
polynucleotide
Prior art date
Application number
PCT/US2003/024844
Other languages
French (fr)
Other versions
WO2004011626A2 (en
Inventor
Hanan Polansky
Original Assignee
Hanan Polansky
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hanan Polansky filed Critical Hanan Polansky
Priority to EP03772197A priority Critical patent/EP1563092A4/en
Priority to CA002518732A priority patent/CA2518732A1/en
Priority to AU2003265386A priority patent/AU2003265386A1/en
Publication of WO2004011626A2 publication Critical patent/WO2004011626A2/en
Publication of WO2004011626A3 publication Critical patent/WO2004011626A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered

Abstract

A recent discovery showed that microcompetition between a foreign polynucleotide and a cellular polynucleotide is a risk factor for some of the major chronic diseases. The invention uses this novel discovery to present assays for screening compounds based on their effectiveness in modulating such microcompetition. The effective compounds can be used in treatment of these chronic diseases. The invention also presents diagnostic methods based on microcompetition with foreign polynucleotides.
PCT/US2003/024844 2002-07-31 2003-07-30 Assays and methods based on microcompetition with a foreign polynucleotide WO2004011626A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP03772197A EP1563092A4 (en) 2002-07-31 2003-07-30 Assays and methods based on microcompetition with a foreign polynucleotide
CA002518732A CA2518732A1 (en) 2002-07-31 2003-07-30 Assays and methods based on microcompetition with a foreign polynucleotide
AU2003265386A AU2003265386A1 (en) 2002-07-31 2003-07-30 Assays and methods based on microcompetition with a foreign polynucleotide

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10/209,026 US20040022764A1 (en) 2002-07-31 2002-07-31 Inhibition of microcompetition with a foreign polynucleotide as treatment of chronic disease
US10/209,026 2002-07-31
US10/211,295 US7381526B2 (en) 2002-07-31 2002-08-01 Assays for drug discovery based on microcompetition with a foreign polynucleotide
US10/211,295 2002-08-01

Publications (2)

Publication Number Publication Date
WO2004011626A2 WO2004011626A2 (en) 2004-02-05
WO2004011626A3 true WO2004011626A3 (en) 2004-07-29

Family

ID=32737908

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/024844 WO2004011626A2 (en) 2002-07-31 2003-07-30 Assays and methods based on microcompetition with a foreign polynucleotide

Country Status (5)

Country Link
US (2) US20040022764A1 (en)
EP (1) EP1563092A4 (en)
AU (1) AU2003265386A1 (en)
CA (1) CA2518732A1 (en)
WO (1) WO2004011626A2 (en)

Families Citing this family (149)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040121335A1 (en) * 2002-12-06 2004-06-24 Ecker David J. Methods for rapid detection and identification of bioagents associated with host versus graft and graft versus host rejections
US20030027135A1 (en) * 2001-03-02 2003-02-06 Ecker David J. Method for rapid detection and identification of bioagents
US7666588B2 (en) 2001-03-02 2010-02-23 Ibis Biosciences, Inc. Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
US7718354B2 (en) 2001-03-02 2010-05-18 Ibis Biosciences, Inc. Methods for rapid identification of pathogens in humans and animals
US7226739B2 (en) 2001-03-02 2007-06-05 Isis Pharmaceuticals, Inc Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
US8073627B2 (en) * 2001-06-26 2011-12-06 Ibis Biosciences, Inc. System for indentification of pathogens
US7217510B2 (en) 2001-06-26 2007-05-15 Isis Pharmaceuticals, Inc. Methods for providing bacterial bioagent characterizing information
CA2508726A1 (en) 2002-12-06 2004-07-22 Isis Pharmaceuticals, Inc. Methods for rapid identification of pathogens in humans and animals
US8046171B2 (en) * 2003-04-18 2011-10-25 Ibis Biosciences, Inc. Methods and apparatus for genetic evaluation
US8057993B2 (en) 2003-04-26 2011-11-15 Ibis Biosciences, Inc. Methods for identification of coronaviruses
US7964343B2 (en) * 2003-05-13 2011-06-21 Ibis Biosciences, Inc. Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US8158354B2 (en) * 2003-05-13 2012-04-17 Ibis Biosciences, Inc. Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
US20100035239A1 (en) * 2003-09-11 2010-02-11 Isis Pharmaceuticals, Inc. Compositions for use in identification of bacteria
US20120122099A1 (en) 2003-09-11 2012-05-17 Rangarajan Sampath Compositions for use in identification of bacteria
US8546082B2 (en) 2003-09-11 2013-10-01 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US20080138808A1 (en) * 2003-09-11 2008-06-12 Hall Thomas A Methods for identification of sepsis-causing bacteria
US20060240412A1 (en) * 2003-09-11 2006-10-26 Hall Thomas A Compositions for use in identification of adenoviruses
US8097416B2 (en) 2003-09-11 2012-01-17 Ibis Biosciences, Inc. Methods for identification of sepsis-causing bacteria
US8163895B2 (en) 2003-12-05 2012-04-24 Ibis Biosciences, Inc. Compositions for use in identification of orthopoxviruses
US7666592B2 (en) 2004-02-18 2010-02-23 Ibis Biosciences, Inc. Methods for concurrent identification and quantification of an unknown bioagent
US8119336B2 (en) * 2004-03-03 2012-02-21 Ibis Biosciences, Inc. Compositions for use in identification of alphaviruses
US7494791B2 (en) * 2004-05-13 2009-02-24 Nanobiosym, Inc. Nano-PCR: methods and devices for nucleic acid amplification and detection
CA2567839C (en) 2004-05-24 2011-06-28 Isis Pharmaceuticals, Inc. Mass spectrometry with selective ion filtration by digital thresholding
US20050260609A1 (en) * 2004-05-24 2005-11-24 Lapidus Stanley N Methods and devices for sequencing nucleic acids
US20050266411A1 (en) * 2004-05-25 2005-12-01 Hofstadler Steven A Methods for rapid forensic analysis of mitochondrial DNA
US7811753B2 (en) 2004-07-14 2010-10-12 Ibis Biosciences, Inc. Methods for repairing degraded DNA
GB0424953D0 (en) * 2004-11-11 2004-12-15 Plant Bioscience Ltd Assay
CA2600184A1 (en) * 2005-03-03 2006-09-08 Isis Pharmaceuticals, Inc. Compositions for use in identification of adventitious viruses
US8084207B2 (en) * 2005-03-03 2011-12-27 Ibis Bioscience, Inc. Compositions for use in identification of papillomavirus
US20060286572A1 (en) * 2005-05-16 2006-12-21 Kohne David E Method for producing chemically synthesized and in vitro enzymatically synthesized nucleic acid oligomers
US8026084B2 (en) * 2005-07-21 2011-09-27 Ibis Biosciences, Inc. Methods for rapid identification and quantitation of nucleic acid variants
US7723077B2 (en) 2005-08-11 2010-05-25 Synthetic Genomics, Inc. In vitro recombination method
EP1915461B1 (en) * 2005-08-17 2018-08-01 Dx4U GmbH Composition and method for determination of ck19 expression
EP1937849B1 (en) * 2005-10-27 2019-05-29 The President and Fellows of Harvard College Methods and compositions for labeling nucleic acids
JP5150829B2 (en) * 2005-11-25 2013-02-27 株式会社ダナフォーム Nucleic acid detection and amplification method
US9182398B2 (en) 2006-04-01 2015-11-10 Medical Service Consultation International, Llc Methods and compositions for detecting fungi and mycotoxins
US9862984B2 (en) 2006-04-21 2018-01-09 Nanobiosym, Inc. Single-molecule platform for drug discovery: methods and apparatuses for drug discovery, including discovery of anticancer and antiviral agents
US20100003680A1 (en) * 2006-07-18 2010-01-07 Joern Lewin Method For Determining The Methylation Rate of a Nucleic Acid
US9051601B2 (en) * 2006-08-01 2015-06-09 Gen-Probe Incorporated Methods of nonspecific target capture of nucleic acids
JP5420412B2 (en) * 2006-09-14 2014-02-19 アイビス バイオサイエンシズ インコーポレイティッド Targeted whole genome amplification method for pathogen identification
US20080161197A1 (en) * 2006-12-12 2008-07-03 Kai Qin Lao Method for amplifying monomorphic-tailed nucleic acids
US20100047800A1 (en) * 2007-01-22 2010-02-25 Siemens Healthcare Diagnostics Inc. Reagents and Methods for Detecting CYP2C9 Polymorphisms
JP5680304B2 (en) * 2007-02-23 2015-03-04 アイビス バイオサイエンシズ インコーポレイティッド Rapid forensic DNA analysis
WO2008118809A1 (en) * 2007-03-23 2008-10-02 Ibis Biosciences, Inc. Compositions for use in identification of mixed populations of bioagents
EP2156179B1 (en) 2007-04-04 2021-08-18 The Regents of The University of California Methods for using a nanopore
CA2684570A1 (en) * 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
WO2008151023A2 (en) 2007-06-01 2008-12-11 Ibis Biosciences, Inc. Methods and compositions for multiple displacement amplification of nucleic acids
US20090042205A1 (en) * 2007-07-09 2009-02-12 Baylor College Of Medicine Fluorescence detection of dna breaks using molecular oscillators
WO2009082747A1 (en) * 2007-12-24 2009-07-02 Zeus Scientific, Inc. Methods and compositions including diagnostic kits for the detection of staphylococcus aureus
DE102008008313A1 (en) * 2008-02-07 2009-08-13 Qiagen Gmbh Amplification of bisulfited nucleic acids
KR100987352B1 (en) * 2008-04-15 2010-10-12 주식회사 인트론바이오테크놀로지 PCR primer capable of reducing non-specific amplification and PCR method using the PCR primer
CA2965207C (en) 2008-08-15 2020-12-15 Cascade Biosystems, Inc. Methods using enzymatic amplification cascades for detecting target nucleic acid in a sample
US20100068718A1 (en) 2008-08-22 2010-03-18 Hooper Dennis G Methods and Compositions for Identifying Yeast
US20100075322A1 (en) * 2008-08-22 2010-03-25 Hooper Dennis G Methods and Compositions for Identifying Mycotoxins and Fungal Species
EP2347254A2 (en) 2008-09-16 2011-07-27 Ibis Biosciences, Inc. Sample processing units, systems, and related methods
EP2344893B1 (en) 2008-09-16 2014-10-15 Ibis Biosciences, Inc. Microplate handling systems and methods
EP2349549B1 (en) 2008-09-16 2012-07-18 Ibis Biosciences, Inc. Mixing cartridges, mixing stations, and related kits, and system
EP2463385B1 (en) * 2008-11-13 2014-08-27 RiboxX GmbH Kit for RNA detection
WO2010075116A2 (en) * 2008-12-15 2010-07-01 Life Technologies Corporation Nucleic acid purification apparatus and method
US20100159452A1 (en) * 2008-12-22 2010-06-24 Roche Molecular Systems, Inc. Method For Detecting a Target Nucleic Acid in a Sample
GB0901593D0 (en) 2009-01-30 2009-03-11 Touchlight Genetics Ltd Production of closed linear DNA
US8158936B2 (en) 2009-02-12 2012-04-17 Ibis Biosciences, Inc. Ionization probe assemblies
US8674080B2 (en) * 2009-04-09 2014-03-18 Roche Molecular Systems, Inc. Dye composition for liquid transfer control
JP2010246400A (en) * 2009-04-10 2010-11-04 Olympus Corp Polymorphism identification method
GB2472371B (en) * 2009-04-24 2011-10-26 Selectamark Security Systems Plc Synthetic nucleotide containing compositions for use in security marking of property and/or for marking a thief or attacker
WO2011008972A1 (en) 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Systems for bioagent identification
WO2011008971A1 (en) * 2009-07-17 2011-01-20 Ibis Biosciences, Inc. Lift and mount apparatus
DK2473596T3 (en) 2009-09-03 2018-01-22 Becton Dickinson Co METHODS AND COMPOSITIONS FOR DIRECT CHEMICAL LYSIS
WO2011041695A1 (en) * 2009-10-02 2011-04-07 Ibis Biosciences, Inc. Determination of methylation status of polynucleotides
US8962251B2 (en) 2009-10-08 2015-02-24 Medical Service Consultation International, Llc Methods and compositions for identifying sulfur and iron modifying bacteria
US9890408B2 (en) * 2009-10-15 2018-02-13 Ibis Biosciences, Inc. Multiple displacement amplification
EP4276190A3 (en) * 2009-12-03 2023-12-27 Quest Diagnostics Investments Incorporated Methods for the diagnosis of bacterial vaginosis
US9605307B2 (en) 2010-02-08 2017-03-28 Genia Technologies, Inc. Systems and methods for forming a nanopore in a lipid bilayer
CA2814762A1 (en) * 2010-02-11 2011-08-18 Intelligent Medical Devices, Inc. Oligonucleotides relating to clostridium difficile genes encoding toxin b, toxin a, or binary toxin
EP2536847B1 (en) 2010-02-15 2018-08-08 Cascade Biosystems, Inc. Methods and materials for assessing rna expression
CA2790006C (en) 2010-02-15 2019-09-24 Cascade Biosystems, Inc. Enzymatic amplification methods and materials for detecting contaminatedfood products
WO2011100749A2 (en) 2010-02-15 2011-08-18 Cascade Biosystems, Inc. Methods and materials for detecting viral or microbial infections
US8551701B2 (en) 2010-02-15 2013-10-08 Cascade Biosystems, Inc. Methods and materials for detecting genetic or epigenetic elements
ES2665500T3 (en) * 2010-03-08 2018-04-26 Dana-Farber Cancer Institute, Inc. Enrichment of a complete COLD PCR with reference blocking sequence
EP2614156B1 (en) * 2010-09-07 2018-08-01 The Regents of The University of California Control of dna movement in a nanopore at one nucleotide precision by a processive enzyme
JP5871933B2 (en) * 2010-09-10 2016-03-01 バイオ−ラッド ラボラトリーズ インコーポレーティッド Detection of RNA interaction region in DNA
US9127321B2 (en) * 2010-10-06 2015-09-08 The Translational Genomics Research Institute Method of detecting Coccidioides species
GB201017978D0 (en) 2010-10-25 2010-12-08 Oxitec Ltd Multiplex amplification and detection
EP3564395A1 (en) 2010-12-30 2019-11-06 Foundation Medicine, Inc. Optimization of multigene analysis of tumor samples
WO2012106428A2 (en) * 2011-02-03 2012-08-09 University Of Florida Research Foundation, Inc. Detection methods for target dna
EP2675913B1 (en) 2011-02-15 2016-12-14 Bio-Rad Laboratories, Inc. Detecting methylation in a subpopulation of genomic dna
AU2012219132B2 (en) * 2011-02-15 2016-05-12 Mats Nilsson Bernitz Method for localized in situ detection of mRNA
ES2656557T3 (en) 2011-03-31 2018-02-27 Dana-Farber Cancer Institute, Inc. Method to enrich single-stranded mutant sequences from a mixture of natural and mutant sequences
US8890672B2 (en) * 2011-08-29 2014-11-18 Harnischfeger Technologies, Inc. Metal tooth detection and locating
US9759465B2 (en) 2011-12-27 2017-09-12 Carrier Corporation Air conditioner self-charging and charge monitoring system
EP2778235B1 (en) * 2012-01-18 2019-09-18 Shanghai Blood Centre Multiplex pcr detection method for human rare blood types and kit
EP3287531B1 (en) * 2012-02-28 2019-06-19 Agilent Technologies, Inc. Method for attaching a counter sequence to a nucleic acid sample
JP6181742B2 (en) 2012-04-18 2017-08-16 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ HEV assay
DK2872629T3 (en) * 2012-07-03 2019-12-09 Integrated Dna Tech Inc TM AMPLIFIED BLOCK OIGONUCLEOTIDES AND LURGETS FOR IMPROVED TARGET-ENHANCED AND REDUCED OFF-TARGET SELECTION
US9982313B2 (en) * 2012-08-17 2018-05-29 Roche Molecular Systems, Inc. Compositions and methods for detection of herpes simplex virus 1 and 2
EP2909339B1 (en) 2012-10-18 2018-05-30 IDEXX Laboratories, Inc. Kits comprising controls for nucleic acid amplification
US9410173B2 (en) * 2012-10-24 2016-08-09 Clontech Laboratories, Inc. Template switch-based methods for producing a product nucleic acid
WO2014106076A2 (en) * 2012-12-28 2014-07-03 Quest Diagnostics Investments Incorporated Universal sanger sequencing from next-gen sequencing amplicons
EP2943587A1 (en) * 2013-01-10 2015-11-18 Roche Diagnostics GmbH Improved calibration of high resolution melting
CN105051514B (en) * 2013-01-24 2017-09-01 霍夫曼-拉罗奇有限公司 RT qPCR analyses to the material of the FFPET section micro-dissections from dyeing
US8956821B2 (en) 2013-02-06 2015-02-17 Medical Service Consultation International, Llc Methods and compositions for detecting Aspergillus terreus, Aspergillus niger, and mycotoxins
GB201302257D0 (en) * 2013-02-08 2013-03-27 Nobel Biocare Services Ag Method for measuring bone loss rate
US10933417B2 (en) 2013-03-15 2021-03-02 Nanobiosym, Inc. Systems and methods for mobile device analysis of nucleic acids and proteins
ES2776202T3 (en) * 2013-04-11 2020-07-29 Pelin Sahlen Capture of directed chromosomal conformation
US10889860B2 (en) * 2013-09-24 2021-01-12 Georgetown University Compositions and methods for single G-level HLA typing
CA2923812C (en) 2013-10-17 2023-10-17 Clontech Laboratories, Inc. Methods for adding adapters to nucleic acids and compositions for practicing the same
SG10202012791TA (en) * 2013-11-15 2021-01-28 Akebia Therapeutics Inc Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof
WO2015094861A1 (en) 2013-12-17 2015-06-25 Clontech Laboratories, Inc. Methods for adding adapters to nucleic acids and compositions for practicing the same
US20150252407A1 (en) * 2014-03-09 2015-09-10 Nvigen, Inc. Nanostructure and methods of nucleic acid isolation
EP2924127A1 (en) * 2014-03-27 2015-09-30 Université Paul Sabatier Toulouse III Method and kit for prognosis of OPA1 gene induced diseases, e.g. Kjers optic atrophy.
US11473080B2 (en) 2014-04-30 2022-10-18 The Board Of Trustees Of The University Of Illinois Method for generating high affinity, bivalent binding agents for sandwich assays
US20150315566A1 (en) * 2014-04-30 2015-11-05 The Board Of Trustees Of The University Of Illinois Method for generating high affinity, bivalent binding agents
US9845507B2 (en) * 2014-09-30 2017-12-19 Sysmex Corporation Methods for detecting oncogenic mutations
GB201418980D0 (en) * 2014-10-24 2014-12-10 Univ Portsmouth Cell assay kit and method
US10697028B2 (en) * 2014-11-06 2020-06-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Detection of HIV-1 nucleic acids by reverse-transcription loop-mediated isothermal amplification
JP6905934B2 (en) 2014-12-05 2021-07-21 ファウンデーション・メディシン・インコーポレイテッド Multiple gene analysis of tumor samples
US11098348B2 (en) * 2015-02-02 2021-08-24 Ontera Inc. Nanopore detection of target polynucleotides from sample background
US10550438B2 (en) * 2015-03-16 2020-02-04 Gen-Probe Incorporated Methods and compositions for detecting bacterial nucleic acid
EP3283645B1 (en) * 2015-04-17 2019-03-27 Roche Diagnostics GmbH Multiplex pcr to detect gene fusions
US20160333396A1 (en) * 2015-05-15 2016-11-17 Rex M. Bitner Compositions and methods for determination of nucleic acid amplification status and kit for performing such methods
AU2016263457B2 (en) * 2015-05-18 2020-08-27 Saga Diagnostics Ab Detection of target nucleic acid and variants
CN107849617B (en) * 2015-06-04 2021-11-02 美之贺美蒂股份有限公司 Detection kit for a plurality of target nucleic acids and detection method using the same
US11041850B2 (en) * 2015-07-07 2021-06-22 The Regents Of The University Of California Method for detecting protein-specific glycosylation
AR105291A1 (en) * 2015-07-10 2017-09-20 Bayer Sas METHODS AND SETS OF ELEMENTS FOR THE DETECTION OF THE EARTH
EP3985131A1 (en) * 2016-06-10 2022-04-20 Gen-Probe Incorporated Compositions and methods for detecting zika virus nucleic acid
EP3541959A1 (en) 2016-11-21 2019-09-25 Gen-Probe Incorporated Compositions and methods for detecting or quantifying hepatitis b virus
EP3551756A4 (en) 2016-12-12 2020-07-15 Dana Farber Cancer Institute, Inc. Compositions and methods for molecular barcoding of dna molecules prior to mutation enrichment and/or mutation detection
WO2018165207A1 (en) * 2017-03-06 2018-09-13 Singular Genomic Systems, Inc. Nucleic acid sequencing-by-synthesis (sbs) methods that combine sbs cycle steps
CA3057154A1 (en) * 2017-03-24 2018-09-27 Gen-Probe Incorporated Compositions and methods for detecting or quantifying parainfluenza virus
US20220162712A1 (en) * 2017-04-12 2022-05-26 Momentum Bioscience Limited Detection and delineation of microorganisms
WO2018215375A1 (en) * 2017-05-22 2018-11-29 General Electric Company Improvements in the recovery of nucleic acids from solid supports
US11602750B2 (en) * 2017-05-30 2023-03-14 Roche Molecular Systems, Inc. Customizable sample processing device
US11293059B2 (en) * 2017-06-22 2022-04-05 Life Technologies Corporation Mesylate based master mix
US11174511B2 (en) 2017-07-24 2021-11-16 Dana-Farber Cancer Institute, Inc. Methods and compositions for selecting and amplifying DNA targets in a single reaction mixture
US20190112636A1 (en) * 2017-10-16 2019-04-18 ChromaCode, Inc. Methods and compositions for nucleic acid detection
US11807901B2 (en) * 2017-11-15 2023-11-07 Board Of Regents, The University Of Texas System Methods and kits for using recombinant microorganisms as direct reagents in biological applications
US11713484B2 (en) * 2017-11-16 2023-08-01 New England Biolabs, Inc. Mapping the location, type and strand of damaged and/or mismatched nucleotides in double-stranded DNA
US11021701B2 (en) 2017-11-22 2021-06-01 New England Biolabs, Inc. Method for fragmenting DNA by nick translation
EP3728633A1 (en) * 2017-12-22 2020-10-28 Thermo Fisher Scientific Baltics Uab Polymerase chain reaction composition comprising amines
CN111819288B (en) * 2018-01-26 2023-07-14 北京生命科学研究所 Immune signal amplification method based on hybridization chain reaction
WO2019152860A1 (en) * 2018-02-02 2019-08-08 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Random amplification methods for extremely low input nucleic acids
US11345963B2 (en) * 2018-05-07 2022-05-31 Ebay Inc. Nucleic acid taggants
KR102211972B1 (en) * 2018-08-02 2021-02-04 엑소젠 피티이. 엘티디 Method for early diagnosis of breast cancer and monitoring after treatment using liquid biopsy multi-cancer gene biomarkers
US20210355527A1 (en) * 2018-09-27 2021-11-18 Cortexyme, Inc. Methods for detection of microbial nucleic acids in body fluids
WO2020086834A1 (en) 2018-10-25 2020-04-30 Singular Genomics Systems, Inc. Nucleotide analogues
US20210371905A1 (en) * 2020-05-26 2021-12-02 Vanderbilt University Surveillance method to screen asymptomatic essential workers for exhalation of sars-cov-2
US11965217B2 (en) * 2020-07-21 2024-04-23 Delta Electronics, Inc. Method and kit for detecting Mycobacterium tuberculosis
KR102417665B1 (en) * 2020-11-16 2022-07-05 조선대학교산학협력단 Composition for detecting Leptospirosis and method of diagnosing Leptospirosis using the same
WO2022257002A1 (en) * 2021-06-08 2022-12-15 Shanghai Focusgen Biotech Ltd Rt-pcr detection reagent for detecting novel coronavirus, kit and detection method thereof

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014812A2 (en) * 1995-10-16 1997-04-24 Chiron Corporation Method of screening for factors that modulate gene expression
US5639613A (en) * 1992-05-13 1997-06-17 Board Of Regents, University Of Texas System Methods for cancer diagnosis and prognosis
US5824475A (en) * 1993-07-19 1998-10-20 Gen-Probe Incorporated Oligonucleotide screening assay using DNA-altering agents and probes with protectable labels
US6117638A (en) * 1997-04-04 2000-09-12 The Regents Of The University Of California Methods to screen for transcription factor-coactivator interactions
US6174868B1 (en) * 1992-09-10 2001-01-16 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of hepatitis C virus-associated diseases
US6210875B1 (en) * 1996-08-22 2001-04-03 Northwestern University Process of determining the efficacy of drug treatment in HIV infected subjects

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0536563B1 (en) * 1991-10-09 2000-01-12 Dade Behring Marburg GmbH Nuclear inhibitor I-92 and its use for the production of a medicament
US5645982A (en) * 1993-08-19 1997-07-08 Systemix, Inc. Method for screening potential therapeutically effective antiviral agents
WO1999024595A1 (en) * 1997-11-12 1999-05-20 The Brigham And Women's Hospital, Inc. The translation enhancer element of the human amyloid precursor protein gene
US6060310A (en) * 1997-11-24 2000-05-09 The United States Of America As Represented By The Department Of Health And Human Services Transcription factor decoy and tumor growth inhibitor
US20030092601A1 (en) * 1999-12-07 2003-05-15 Hanan Polansky Microcompetition and human disease

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639613A (en) * 1992-05-13 1997-06-17 Board Of Regents, University Of Texas System Methods for cancer diagnosis and prognosis
US6174868B1 (en) * 1992-09-10 2001-01-16 Isis Pharmaceuticals, Inc. Compositions and methods for treatment of hepatitis C virus-associated diseases
US5824475A (en) * 1993-07-19 1998-10-20 Gen-Probe Incorporated Oligonucleotide screening assay using DNA-altering agents and probes with protectable labels
WO1997014812A2 (en) * 1995-10-16 1997-04-24 Chiron Corporation Method of screening for factors that modulate gene expression
US6210875B1 (en) * 1996-08-22 2001-04-03 Northwestern University Process of determining the efficacy of drug treatment in HIV infected subjects
US6117638A (en) * 1997-04-04 2000-09-12 The Regents Of The University Of California Methods to screen for transcription factor-coactivator interactions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP1563092A4 *

Also Published As

Publication number Publication date
EP1563092A4 (en) 2009-05-06
US20040023207A1 (en) 2004-02-05
AU2003265386A8 (en) 2004-02-16
US20040022764A1 (en) 2004-02-05
EP1563092A2 (en) 2005-08-17
WO2004011626A2 (en) 2004-02-05
AU2003265386A1 (en) 2004-02-16
CA2518732A1 (en) 2004-02-05
US7381526B2 (en) 2008-06-03

Similar Documents

Publication Publication Date Title
WO2004011626A3 (en) Assays and methods based on microcompetition with a foreign polynucleotide
WO2006122156A3 (en) Compounds for modulating trpv3 function
WO2007056124A3 (en) Compounds for modulating trpv3 function
AU2002366641A1 (en) Methods for inhibiting ocular processes
WO2005032488A3 (en) 2,4-dioxo-3-quinazolinylaryl sulfonylureas
WO2005039504A3 (en) Compounds and methods for treating toll-like receptor 2-related diseases and conditions
WO2006068729A3 (en) Methods and compositions for enhancing iron absorption
WO2006114105A8 (en) Use of modified factor vii for treating bleeding
WO2006034491A3 (en) Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes
WO2006016262A8 (en) Combination of a selective noradrenaline reuptake inhibitor and a pdev inhibitor
WO2005085861A3 (en) Nucleic acids and encoded polypeptides for use in liver disorders and epithelial cancer
WO2003026643A3 (en) Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
PT1300084E (en) COMPOSITION FOR THE TREATMENT OF CHRONIC VENOUS INSUFFICIENCIES MELHA.
AU2003286285A1 (en) Use of fgf-18 in the diagnosis and treatment of memory disorders
WO2002030354A3 (en) Uridine therapy for patients with elevated purine levels
WO2003070169A3 (en) Aminodiphosphonate apolipoprotein e modulators
WO2003062345A3 (en) Treatments of solid substrates to enhance durability of treatments placed thereon
FR2843167B1 (en) DEVICE FOR THE CATALYTIC TREATMENT OF GASEOUS MEDIA
WO2002062205A3 (en) Methods for diagnosing and treating heart disease
WO2005009383A3 (en) Methods of treatment with lxr agonists
WO2003028536A3 (en) Methods for diagnosing and treating heart disease
EP1649870A3 (en) Treatment of autoimmune diseases with antagonists which bind to B cell surface markers
WO2003095485A3 (en) Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
AU2003290560A1 (en) Inmould process for the spheroidization and inoculation treatment of cast sg iron

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003772197

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003772197

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2518732

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP